Serum-free produced Bovine Herpesvirus type 1 and Bovine Parainfluenza type 3 virus vaccines are efficacious and safe

被引:8
作者
Makoschey, B
Patel, JR
van Gelder, PTJA
机构
[1] Intervet Int BV, Dept Virol R&D, NL-5839 AA Boxmeer, Netherlands
[2] Intervet UK Ltd, Bovine & Equine Res Lab, Huntingdon, England
[3] Intervet Int BV, Biol All Purpose Pilot Plant, Boxmeer, Netherlands
关键词
Bovine Herpesvirus 1 (BHV-1); Bovine Parainfluenza type 3 (PI3); fetal calf serum; serum-free; vaccine;
D O I
10.1023/A:1023982003258
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The studies described in this report were performed to determine, whether it is possible to produce live virus vaccines without serum or fractions thereof used during any cell or virus passage, thus completely serum-free. Two viruses were included in the experiments: Bovine Herpesvirus 1 ( BHV-1) and Bovine Parainfluenza type 3 virus (PI3). Both viruses were found to grow to satisfactory titers, and to be stable after freeze-drying and subsequent storage at temperatures of +4 degreesC and -20 degreesC for at least one year. Moreover, a vaccine containing serum free produced BHV-1 was tested in a vaccination-challenge experiment. For comparison, a vaccine batch with BHV-1 grown in serum-containing cell culture medium was included in the study. Both vaccine preparations performed equally well and both met the strict requirements as laid down in the European Phamacopeia. Moreover, in two separate experiments the safety of serum-free produced BHV-1 and PI3 after overdose and repeated administration even in very young calves and even after four administrations has been demonstrated. This report is the first, which to our knowledge demonstrates the safety and efficacy of serum-free produced live vaccines in the target animal as well as the stability of these products.
引用
收藏
页码:139 / 145
页数:7
相关论文
共 30 条
[1]  
Bolin S R, 1991, J Vet Diagn Invest, V3, P199
[2]  
Cruz PE, 1998, BIOTECHNOL BIOENG, V60, P408, DOI 10.1002/(SICI)1097-0290(19981120)60:4<408::AID-BIT2>3.3.CO
[3]  
2-C
[4]  
Falcone E, 1999, VACCINE, V18, P387
[5]  
Froud S J, 1999, Dev Biol Stand, V99, P157
[6]   EVIDENCE OF PESTIVIRUS RNA IN HUMAN VIRUS-VACCINES [J].
HARASAWA, R ;
TOMIYAMA, T .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (06) :1604-1605
[7]   ADVENTITIOUS PESTIVIRUS RNA IN LIVE VIRUS-VACCINES AGAINST BOVINE AND SWINE DISEASES [J].
HARASAWA, R .
VACCINE, 1995, 13 (01) :100-103
[8]   Sequence analysis of the 5' untranslated region of pestivirus RNA demonstrated in interferons for human use [J].
Harasawa, R ;
Sasaki, T .
BIOLOGICALS, 1995, 23 (04) :263-269
[9]   INACTIVATION OF VIRAL AGENTS IN BOVINE SERUM BY GAMMA-IRRADIATION [J].
HOUSE, C ;
HOUSE, JA ;
YEDLOUTSCHNIG, RJ .
CANADIAN JOURNAL OF MICROBIOLOGY, 1990, 36 (10) :737-740
[10]   Detection of bovine polyomavirus contamination in fetal bovine sera and modified live viral vaccines using polymerase chain reaction [J].
Kappeler, A ;
LutzWallace, C ;
Sapp, T ;
Sidhu, M .
BIOLOGICALS, 1996, 24 (02) :131-135